Cargando…
Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model
Over 182 million confirmed cases of COVID-19 and more than 4 million deaths have been reported to date around the world. It is essential to identify broad-spectrum antiviral agents that may prevent or treat infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) but also by other...
Autores principales: | Alsaidi, Sahar, Cornejal, Nadjet, Mahoney, Oneil, Melo, Claudia, Verma, Neeharika, Bonnaire, Thierry, Chang, Theresa, O’Keefe, Barry R., Sailer, James, Zydowsky, Thomas M., Teleshova, Natalia, Romero, José A. Fernández |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400000/ https://www.ncbi.nlm.nih.gov/pubmed/34436255 http://dx.doi.org/10.3390/md19080418 |
Ejemplares similares
-
Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus
por: Levendosky, Keith, et al.
Publicado: (2015) -
Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel
por: Teleshova, Natalia, et al.
Publicado: (2022) -
Antiviral activity of aframomum melegueta against severe acute respiratory syndrome coronaviruses type 1 and 2
por: Mahoney, Oneil, et al.
Publicado: (2022) -
Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo
por: Derby, Nina, et al.
Publicado: (2018) -
Crystallographic studies of the complexes of antiviral protein griffithsin with glucose and N-acetylglucosamine
por: Ziółkowska, Natasza E., et al.
Publicado: (2007)